[17] In November 2025, Pfizer won a bidding war with Novo Nordisk, acquiring obesity drug developer, Metsera
For many patients, this dual benefit, which is better blood sugar control and weight reduction, makes semaglutide-based treatments especially appealing
Mounjaro Diarrhea, Constipation, and Stomach Pain: Complete GI Side Effects Guide By Dr
In a separate meta-analysis, 21.7% of overweight/obese children were diagnosed with depression and 39.8% with anxiety, but only 18.0% of non-overweight/non-obese children had depression and 14.0% had anxiety, further stressing the importance of prioritizing effective treatment strategies4
( B ) Percentage of , , and cells in saline- and liraglutide-treated islets from the 3 individual donors (D1D3) and in the combined data set (CD)